Cannabix's Marijuana Breath Test Lands on AlcoPro's 2026 Catalog Cover

Event summary

  • Cannabix's Marijuana Breath Test (MBT) will be featured on the cover of AlcoPro's 2026 product catalog.
  • AlcoPro will distribute the catalog to over 85,000 businesses, including law enforcement and corrections segments.
  • Cannabix and AlcoPro have been collaborating on pre-launch marketing activities for the MBT in the U.S. market.
  • The MBT system combines Cannabix’s proprietary Breath Collection Unit and Breath Cartridge technologies for LC-MS analysis.

The big picture

Cannabix's feature on AlcoPro's catalog cover underscores the growing demand for advanced, non-invasive drug testing solutions in both workplace and law enforcement settings. The partnership with Omega Laboratories Inc. further strengthens Cannabix's position in the forensic drug testing market, leveraging decades of expertise and certifications. This strategic move comes as safety challenges evolve, pushing employers and law enforcement to adopt proactive technologies that reduce risk.

What we're watching

Market Adoption
How the MBT's integration into AlcoPro's catalog will impact its adoption by law enforcement and workplace safety segments.
Regulatory Compliance
Whether the MBT can meet the stringent accuracy standards required for forensic drug testing.
Competitive Positioning
The pace at which Cannabix can differentiate itself in the growing market for non-invasive drug testing solutions.